GLP-1 Titration, Dosing Schedules, and Missed Doses

Your injection day came and went. Now it is Tuesday, you are not sure how many days have passed, and your prescriber is unreachable until Monday. The answer depends on which drug you are using and how much time has gone by. This article covers GLP-1 titration logic, the missed-dose rules for semaglutide and tirzepatide, and what to do if you are managing this in Bangkok without a regular doctor nearby.

GLP-1 titration is not complicated once you understand why doses start low. The schedule is set by the manufacturer, not by preference. If side effects hit hard, you slow down. If you miss a dose, there are clear rules. Both are covered below.

Why GLP-1 Doses Start Low and Rise Gradually

Your gut is not used to these medications. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) slow how quickly your stomach empties food. At a full maintenance dose, that effect is strong. Starting there immediately would cause significant nausea and vomiting for most people.

The step-up schedule gives your gut time to adapt. Each dose sits for several weeks before the next increase. By the time you reach a higher dose, the early intensity has settled. This is not a slow path to results. It is how the drug works safely over the long term.

Both semaglutide and tirzepatide follow a step-up schedule set by their prescribing labels. These are not optional starting points. Rushing the escalation schedule is a recognised reason patients stop treatment early due to severe gastrointestinal side effects. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2) should not use these medications, and anyone who develops signs of pancreatitis such as severe persistent stomach pain should seek medical attention promptly.

What GLP-1 Titration Is Actually Trying to Achieve

The goal is not to reach the maximum dose as fast as possible. The goal is the lowest effective dose that gives you meaningful results with tolerable side effects. For some patients, that is a mid-range dose. For others, a full maintenance dose is necessary. Both are clinically valid outcomes.

Higher doses generally produce greater weight loss. But the difference between dose steps is not large enough to justify pushing through severe nausea. A patient who tolerates a moderate dose and stays on it for a year will do better than one who escalates quickly and stops after three months.

Titration manages the balance between effectiveness and tolerability. Following the schedule is not holding you back. It is protecting your ability to stay on the medication.

Missed-Dose Rules for Semaglutide and Tirzepatide

The rules differ by drug, and they come from each product’s prescribing label.

For semaglutide, the missed-dose window depends on the product. For Ozempic, you have a five-day window after the missed injection day: take it if you are within five days, then resume your normal weekly schedule from that new date. For Wegovy (per the FDA label), take the missed dose only if your next scheduled dose is more than two days (48 hours) away. If less than two days remain before your next dose, skip it. If more than five days (Ozempic) or two days (Wegovy) have passed, skip the missed dose and wait for your next scheduled dose.

For tirzepatide (Mounjaro), the window is four days (96 hours). Same principle: take it if you are within four days, skip it if not. Do not take two doses in one week to compensate. Doubling up does not recover lost progress and significantly increases the risk of severe nausea.

These rules do not transfer between drugs. If you have switched medications, apply the rule for the one you are currently using. The Doctor Bangkok GLP-1 service page covers this in more detail, including how many days late you can take a weekly injection.

When to Skip Versus When to Call

Skip and continue if you missed the window and feel fine, or you simply forgot and it has been more than five days from the missed dose (Ozempic), more than two days before your next dose (Wegovy), or more than four days from the missed dose (tirzepatide). Your next injection goes on its usual day. No dose adjustment, no need to drop back a step.

Call your prescriber if you have missed multiple doses in a row, stopped for more than two weeks, experienced persistent vomiting that prevented injecting, or are unsure which dose to restart at. These situations usually require re-titration from a lower step, not simply resuming where you left off.

Nausea, Plateaus, and Staying Longer on a Dose

If nausea is significant at your current dose, staying on it longer before escalating is clinically reasonable. Most prescribing guidelines acknowledge extended titration as a valid approach for patients with GI sensitivity. You are not failing the medication.

In rare cases, GLP-1 medications can cause significant slowing of gastric emptying that goes beyond normal adaptation. If nausea persists for weeks rather than days, if you are vomiting regularly, or if you cannot eat a normal meal, that warrants a clinical assessment rather than patience.

Weight loss plateaus mid-titration are common and often temporary. Before increasing your dose, confirm the plateau has lasted several weeks and rule out other factors including sleep, stress, and caloric intake. A dose increase is one option. Optimising the current dose is another. Both are worth discussing with a prescriber before deciding.

If you are tracking your weight alongside this, the BMI calculator on the Doctor Bangkok site gives you a useful baseline in kilograms and centimetres.

Follow Your Prescribed Schedule, Not Internet Charts

The internet has no shortage of titration schedules. Some are accurate. Some are outdated. Some come from clinical trial protocols that differ from standard prescribing practice. None of them know your medical history, your current dose, your side effect pattern, or what other medications you are taking.

In Bangkok specifically, injectable GLP-1 pens have required a Thai FDA prescription since September 2026, when the Public Health Ministry reclassified them as specially controlled drugs. Pens sold without one, including those circulating through social media sellers and informal suppliers, carry a real risk of being counterfeit. Counterfeit pens may contain the wrong concentration or no active ingredient at all, and cold-chain storage is not guaranteed. This is not a minor risk. It directly affects whether your titration works at all.

If you are managing your GLP-1 schedule in Bangkok and need a prescription, a dose review, or a titration adjustment, Doctor Bangkok’s weight-loss injection service operates around the clock. Walk in to the clinic on Sukhumvit Soi 13, or request a doctor-on-call visit to your hotel or condo anywhere in Bangkok within the hour.